447 related articles for article (PubMed ID: 9209493)
21. One cause for the apparent inability of human T cell clones to function as professional superantigen-presenting cells is autoactivation.
Nisini R; Fattorossi A; Ferlini C; D'Amelio R
Eur J Immunol; 1996 Apr; 26(4):797-803. PubMed ID: 8625970
[TBL] [Abstract][Full Text] [Related]
22. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
Chen FL; Kung JT
J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
[TBL] [Abstract][Full Text] [Related]
23. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
de Waal Malefyt R; Yssel H; de Vries JE
J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
[TBL] [Abstract][Full Text] [Related]
24. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
Damle NK; Doyle LV
J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
[TBL] [Abstract][Full Text] [Related]
25. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
Hirokawa M; Gray JD; Takahashi T; Horwitz DA
J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
[TBL] [Abstract][Full Text] [Related]
26. Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4-Ig protects V beta 8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B.
Lane P; Haller C; McConnell F
Eur J Immunol; 1996 Apr; 26(4):858-62. PubMed ID: 8625979
[TBL] [Abstract][Full Text] [Related]
27. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
Brogan PA; Shah V; Klein N; Dillon MJ
Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
[TBL] [Abstract][Full Text] [Related]
28. TCR-independent activation of human CD4+ 45RO- T cells by anti-CD28 plus IL-2: Induction of clonal expansion and priming for a Th2 phenotype.
Brinkmann V; Kinzel B; Kristofic C
J Immunol; 1996 Jun; 156(11):4100-6. PubMed ID: 8666775
[TBL] [Abstract][Full Text] [Related]
29. Direct activation of murine resting T cells by con A or anti-CD3 Ig.
Quintáns J; Yokoyama A; Evavold B; Hirsch R; Mayforth RD
J Mol Cell Immunol; 1989; 4(4):225-35; discussion 235-7. PubMed ID: 2532886
[TBL] [Abstract][Full Text] [Related]
30. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA
Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325
[TBL] [Abstract][Full Text] [Related]
31. Presentation of superantigen by human T cell clones: a model of T-T cell interaction.
Nisini R; Matricardi PM; Fattorossi A; Biselli R; D'Amelio R
Eur J Immunol; 1992 Aug; 22(8):2033-9. PubMed ID: 1353448
[TBL] [Abstract][Full Text] [Related]
32. Role of IL-6, IL-1, and CD28 signaling in responses of mouse CD4+ T cells to immobilized anti-TCR monoclonal antibody.
Holsti MA; McArthur J; Allison JP; Raulet DH
J Immunol; 1994 Feb; 152(4):1618-28. PubMed ID: 7907103
[TBL] [Abstract][Full Text] [Related]
33. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
[TBL] [Abstract][Full Text] [Related]
34. The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation.
Tohma S; Hirohata S; Lipsky PE
J Immunol; 1991 Jan; 146(2):492-9. PubMed ID: 1670945
[TBL] [Abstract][Full Text] [Related]
35. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes.
Frandji P; Tkaczyk C; Oskeritzian C; David B; Desaymard C; Mécheri S
Eur J Immunol; 1996 Oct; 26(10):2517-28. PubMed ID: 8898968
[TBL] [Abstract][Full Text] [Related]
36. Post-thymic maturation of migrating human thymic single-positive T cells: thymic CD1a- CD4+ T cells are more susceptible to anergy induction by toxic shock syndrome toxin-1 than cord blood CD4+ T cells.
Imanishi K; Seo K; Kato H; Miyoshi-Akiyama T; Zhang RH; Takanashi Y; Imai Y; Uchiyama T
J Immunol; 1998 Jan; 160(1):112-9. PubMed ID: 9551963
[TBL] [Abstract][Full Text] [Related]
37. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not by IL-4 or IL-13.
Fasler S; Aversa G; Terr A; Thestrup-Pedersen K; de Vries JE; Yssel H
J Immunol; 1995 Nov; 155(9):4199-206. PubMed ID: 7594575
[TBL] [Abstract][Full Text] [Related]
38. IL-2 and a contact-mediated signal provided by TCR alpha beta + or TCR gamma delta + CD4+ T cells induce polyclonal Ig production by committed human B cells. Enhancement by IL-5, specific inhibition of IgA synthesis by IL-4.
van Vlasselaer P; Gascan H; de Waal Malefyt R; de Vries JE
J Immunol; 1992 Mar; 148(6):1674-84. PubMed ID: 1347306
[TBL] [Abstract][Full Text] [Related]
39. Ligation of TAPA-1 (CD81) or major histocompatibility complex class II in co-cultures of human B and T lymphocytes enhances interleukin-4 synthesis by antigen-specific CD4+ T cells.
Secrist H; Levy S; DeKruyff RH; Umetsu DT
Eur J Immunol; 1996 Jul; 26(7):1435-42. PubMed ID: 8766544
[TBL] [Abstract][Full Text] [Related]
40. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen.
Kuroda K; Yagi J; Imanishi K; Yan XJ; Li XY; Fujimaki W; Kato H; Miyoshi-Akiyama T; Kumazawa Y; Abe H; Uchiyama T
J Immunol; 1996 Aug; 157(4):1422-31. PubMed ID: 8759722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
